Non-animal stabilised hyaluronic acid in the treatment of osteoarthritis of the knee: A tolerability study

Clinical Drug Investigation

Volumn 22, Issue 3, 2002, Pages 157-166

  Akermark C ^a   Berg, P ^b   Bjorkman A ^c   Malm, P ^d  

^a Ortopediska Huset   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c Aros Lakarmottagning   (Sweden)

^d Odensala Hälsocentral   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTZAL; CORTICOSTEROID; DUROLANE; HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PRIORITY JOURNAL;

EID: 0036209864     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200222030-00002     Document Type: Article

References (28)

1. Social and economic impacts of four musculoskeletal conditions
2. Epidemiology of musculoskeletal impairments and associated disability
3. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
4. How serious is knee osteoarthritis?
5. Another look at osteoarthritis
6. Epidemiological aspects of osteoarthritis - An interview survey of the Swedish population and a review of previous studies
7. Recommendations for the medical management of osteoarthritis of the hip and knee
8. Nonsteroidal anti-inflammatory drug gastropathy
9. Risk for serious gastrointestinal complications related to use of non-steroidal anti-inflammatory drugs
10. Drug-related admissions to a department of medical gastroenterology. The role of self-medicated and prescribed drugs
11. Non-steroidal anti-inflammatory drugs: Assessment of risks
12. Direct medical costs of disease and gastrointestinal side-effects during treatment for arthritis
13. Non-steroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons
14. Local corticosteroid injection treatment in rheumatic disorders
15. Guidelines for the medical management of osteoarthritis
16. Hyaluronan: Biological role and function in articular joints
17. A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology
18. Visco-supplementation with hylan for the treatment of osteoarthritis: Findings from clinical practice in Canada
19. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: A randomised, double-blind, placebo controlled multicentre trial
20. Controlled single-blind trial of intraarticularly injected hyaluronic acid in osteoarthritis of the knee
21. Clinical trial of intraarticular injection of sodium hyaluronate in patients with osteoarthritis of the knee
22. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: A 1 year placebo-controlled trial
23. An analysis of clinical studies of the use of cross-linked hyaluroan, hylan, in the treatment of osteoarthritis
24. Intra-articular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: Randomised clinical trial
25. Acute local reactions after intra-articular hytan for osteoarthritis of the knee
26. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: A randomised single centre double-blind placebo controlled trial of 91 patients demonstrating lack of efficacy
27. Intra-articular hyaluronan injections in the treatment of osteoarthrosis: State of the art review